April 29, 2014 by admin New Report Cautions Marijuana As Treatment For MS Marijuana has been approved for medicinal purposes in a number of U.S. states, however it still remains a much debated issue according to the American Academy of Neurology.Ā New information has been released by ANN Annual Meeting in Philadelphia, PA.Ā This represents the largest gathering of neurologists globally. According…
April 28, 2014 by Maureen Newman Knockdown of Retinoblastoma Enhances Nerve Regeneration in Multiple Sclerosis & Other Diseases Nerve cells are notoriously difficult to regenerate, but according to a recent article inĀ Science Daily, a research group from University of Galgary’s Hotchkiss Brain Institute (HBI) has discovered a new way to turn onĀ neural cell growth, which would be beneficial for treating nerve damage commonly found in diseases…
April 21, 2014 by Charles Moore Supreme Court Denies Injunction Request To Block Release Of Generic MS Drug, But Patent Fight Not Over Yet Petah Tikvah Israel-basedĀ Teva Pharmaceutical Industries Ltd.Ā has suffered a setback in its fight to forestall release of generic competitors for its proprietary Copaxone Multiple Sclerosis drug. However, the company is expressing optimism that potential for recovery of Patent Infringement Damages may dissuade aspirant generic competitors from proceeding until a…